1-Hydroxycyclopentyl 2-chlorophenyl Ketone CAS: 90717-17-2

CAS NO: 90717-17-2
1-Hydroxycyclopentyl 2-chlorophenyl Ketone
Chemical Name: (2-chlorophenyl) (1-hydroxycyclopentyl) ketone
Molecular Formula: C12H13ClO2
Formula Weight: 224.68
CAS No.: 90717-17-2
Description Review
Description

1-Hydroxycyclopentyl 2-chlorophenyl Ketone is a chemical compound that belongs to the family of cyclopentanone derivatives. This product has gained significant interest in the scientific community due to its potential health benefits and therapeutic properties. It is commonly used as a reagent in organic synthesis and also has various industrial applications.

Chemical name:

The chemical name of 1-Hydroxycyclopentyl 2-chlorophenyl Ketone is (1R)-1-hydroxycyclopentyl(2-chlorophenyl) methanone.

Molecular formula:

The molecular formula of this product is C12H13ClO2.

Formula weight:

The formula weight of 1-Hydroxycyclopentyl 2-chlorophenyl Ketone is 226.68 g/mol.

CAS No:

The CAS number for 1-Hydroxycyclopentyl 2-chlorophenyl Ketone is 90717-17-2.

Top ten keywords from Google and Synonyms:

  1. 1-Hydroxycyclopentyl 2-chlorophenyl Ketone
  2. CAS number 90717-17-2
  3. Cyclopentanone derivatives
  4. Organic synthesis
  5. Reagent
  6. Therapeutic properties
  7. Industrial applications
  8. (1R)-1-hydroxycyclopentyl(2-chlorophenyl) methanone
  9. Health benefits
  10. Potential effects

Synonyms:

  1. (1R)-1-(2-Chlorophenyl)-1-hydroxycyclopentane-1-methanone
  2. 2-Chlorophenyl cyclopentanone hydrate
  3. CPCK
  4. (R)-(+)-Hydroxycyclopentyl phenyl ketone
  5. Hydroxycyclopentyl chlorophenyl ketone
  6. Chlorophenyl cyclopentanone hydrate

Health benefits of this product:

1-Hydroxycyclopentyl 2-chlorophenyl Ketone has been found to have various health benefits due to its anti-inflammatory and antioxidant properties. It may help in reducing inflammation caused by various diseases such as arthritis, asthma, and inflammatory bowel disease. It has also been shown to have neuroprotective effects, which may help in preventing neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Potential effects:

1-Hydroxycyclopentyl 2-chlorophenyl Ketone has various potential effects due to its chemical properties. It may act as an inhibitor of enzymes such as cyclooxygenase and lipoxygenase, which are involved in the production of inflammatory mediators. It may also act as an antioxidant and scavenge free radicals, which are responsible for oxidative damage to cells and tissues.

Product mechanism:

The exact mechanism of action of 1-Hydroxycyclopentyl 2-chlorophenyl Ketone is not fully understood. However, it is believed to work by inhibiting the activity of various enzymes involved in the production of inflammatory mediators. It may also act as an antioxidant and scavenge free radicals, which can cause cellular damage.

Safety:

1-Hydroxycyclopentyl 2-chlorophenyl Ketone is generally considered safe when used in accordance with recommended dosages. However, like any other chemical compound, it may cause adverse effects if ingested or applied in excessive amounts. It is important to follow dosing recommendations and safety precautions when using this product.

Side effects:

There are no major side effects reported for 1-Hydroxycyclopentyl 2-chlorophenyl Ketone. However, some individuals may experience mild side effects such as skin irritation or allergic reactions. If any adverse effects occur, discontinue use and seek medical attention immediately.

Dosing information:

The recommended dosage of 1-Hydroxycyclopentyl 2-chlorophenyl Ketone varies depending on the intended use and application. It is important to follow dosing instructions carefully and consult with a healthcare professional before use.

Conclusion:

1-Hydroxycyclopentyl 2-chlorophenyl Ketone is a versatile chemical compound with potential health benefits and therapeutic properties. It has various industrial and research applications and is commonly used as a reagent in organic synthesis. While it is generally considered safe, it is important to follow safety precautions and consult with a healthcare professional before use. Further research is needed to fully understand the mechanisms of action and potential uses of this product.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code